Integra LifeSciences: reports Q3 2026 preliminary revenue of $410,000,000 to $412,000,000

What happened

• On Oct 2, 2026, Integra LifeSciences Holdings Corporation announced preliminary unaudited results for the third quarter ended Sep 30, 2026. The Company expects reported revenue to be between $410,000,000 and $412,000,000, reflecting an estimated $7,000,000 impact from flooding-related supply disruptions at its Cincinnati, Ohio manufacturing facility. The Company expects adjusted earnings per diluted share to be between $0.55 and $0.59 and expects operating cashflow to be greater than $85,000,000. The filing states these results are unaudited, preliminary, subject to completion of financial closing procedures and have not been reviewed by the Company’s independent registered public accounting firm.

Key details

• The Company issued a press release on Oct 2, 2026 announcing the preliminary results and providing an update on the Cincinnati facility.
• The filing references adjusted earnings per diluted share as a non-GAAP measure (adjusted net income excludes items such as structural optimization charges; divestiture, acquisition and integration-related charges; EU Medical Device Regulation-related charges; charges related to the Braintree transition; intangible asset amortization; income tax impacts from adjustments; and impairment charges).
• The Company did not provide a reconciliation from GAAP earnings per share to adjusted earnings per diluted share, stating certain GAAP expense items are highly variable and cannot be predicted with reasonable certainty at this time.
• The filing includes forward-looking statements about the preliminary results, the estimated impact of the Cincinnati flooding, recovery efforts, timing and costs, and expected insurance coverage and recoveries.

Why it may matter

• Item 2.02 (results of operations and financial condition) was reported, covering preliminary third quarter financial results and cashflow expectations. Item 7.01 (Regulation FD disclosure) was reported by issuing a press release with the above information. A filing does not show why the insider traded or why the company acted.